Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)

被引：6
作者：
Gupta, S. [1 ]
Climent Duran, M. A. [2 ]
Sridhar, S. [3 ]
Powles, T. B. [4 ]
Bellmunt, J. [5 ]
Tyroller, K. [6 ]
Guenther, S. [7 ]
di Pietro, A. [8 ]
Grivas, P. [9 ]
机构：
[1] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA
[2] Inst Valenciano Oncol, Valencia, Spain
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Queen Mary Univ London, Barts Canc Inst, Expt Canc Med Ctr, St Bartholomews Hosp, London, England
[5] Dana Farber Canc Inst, Harvard Med Sch, Dept Med Oncol, Boston, MA USA
[6] EMD Serono Res & Dev Inst Inc, Billerica, MA USA
[7] Merck Healthcare KGaA, Darmstadt, Germany
[8] Pfizer Srl, Milan, Italy
[9] Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2371P
引用
收藏
页码：S1207 / S1207
页数：1
相关论文
共 50 条
[31]   Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up [J].
Powles, Thomas ;
Park, Se Hoon ;
Caserta, Claudia ;
Valderrama, Begona P. ;
Gurney, Howard ;
Ullen, Anders ;
Loriot, Yohann ;
Sridhar, Srikala S. S. ;
Sternberg, Cora N. N. ;
Bellmunt, Joaquim ;
Aragon-Ching, Jeanny B. B. ;
Wang, Jing ;
Huang, Bo ;
Laliberte, Robert J. J. ;
di Pietro, Alessandra ;
Grivas, Petros .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (19) :3486-+
[32]   Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial [J].
Grivas, Petros ;
Park, Se Hoon ;
Voog, Eric ;
Caserta, Claudia ;
Gurney, Howard ;
Bellmunt, Joaquim ;
Kalofonos, Haralabos ;
Ullen, Anders ;
Loriot, Yohann ;
Sridhar, Srikala S. ;
Yamamoto, Yoshiaki ;
Petrylak, Daniel P. ;
Sternberg, Cora N. ;
Gupta, Shilpa ;
Huang, Bo ;
Costa, Nuno ;
Laliberte, Robert J. ;
di Pietro, Alessandra ;
Valderrama, Begona P. ;
Powles, Thomas .
EUROPEAN UROLOGY, 2023, 84 (01) :95-108
[33]   Avelumab first-line maintenance for advanced urothelial carcinoma: long-term follow-up from JAVELIN Bladder 100 in subgroups defined by first-line chemotherapy regimen and overall survival from start of chemotherapy [J].
Sridhar, Srikala S. ;
Powles, Thomas ;
Gupta, Shilpa ;
Duran, Climent Miguel A. ;
Aragon-Ching, Jeanny B. ;
Sternberg, Cora N. ;
Gurney, Howard ;
Cislo, Paul ;
Costa, Nuno ;
di Pietro, Alessandra ;
Bellmunt, Joaquim ;
Grivas, Petros .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 :58-59
[34]   Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC) in the JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval (TFI) from end of chemotherapy to start of maintenance. [J].
Sridhar, Srikala S. ;
Powles, Thomas ;
Loriot, Yohann ;
Duran, Miguel A. Climent ;
Gupta, Shilpa ;
Tsuchiya, Norihiko ;
Bamias, Aristotelis ;
Ardizzoni, Andrea ;
Ullen, Anders ;
Huang, Bo ;
Costa, Nuno Matos ;
Laliberte, Robert J. ;
Di Pietro, Alessandra ;
Sternberg, Cora N. ;
Grivas, Petros .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[35]   Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100 [J].
Grivas, P. ;
Park, S. H. ;
Voog, E. ;
Caserta, C. ;
Perez Valderrama, B. ;
Gurney, H. ;
Kalofonos, H. ;
Radulovic, S. ;
Demey, W. ;
Ullen, A. ;
Loriot, Y. ;
Sridhar, S. S. ;
Tsuchiya, N. ;
Kopyltsov, E. ;
Gupta, S. ;
Huang, B. ;
Costa, N. ;
Blake-Haskins, J. A. ;
di Pietro, A. ;
Powles, T. B. .
ANNALS OF ONCOLOGY, 2020, 31 :S555-S556
[36]   Avelumab first-line maintenance for advanced urothelial carcinoma (aUC) in the phase 3 JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval from end of chemotherapy to start of maintenance [J].
Pook, David W. ;
Sridhar, Srikala S. ;
Powles, Thomas ;
Loriot, Yohann ;
Duran, Miguel A. Climent ;
Gupta, Shilpa ;
Tsuchiya, Norihiko ;
Bamias, Aristotelis ;
Ardizzoni, Andrea ;
Ullen, Anders ;
Huang, Bo ;
Costa, Nuno ;
Laliberte, Robert J. ;
di Pietro, Alessandra ;
Sternberg, Cora N. ;
Grivas, Petros .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 :131-132
[37]   Patient-reported outcomes (PROs) from JAVELIN Bladder 100: Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC) [J].
Powles, T. B. ;
Kopyltsov, E. ;
Su, P-J. ;
Parnis, F. X. ;
Park, S. H. ;
Yamamoto, Y. ;
Fong, P. C. ;
Tournigand, C. ;
Duran, M. A. Climent ;
Bamias, A. ;
Caserta, C. ;
Chang, J. ;
Yan, E. ;
di Pietro, A. ;
Wang, J. ;
Grivas, P. .
ANNALS OF ONCOLOGY, 2020, 31 :S578-S579
[38]   Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses [J].
Zarrabi, Kevin K. ;
Miron, Benjamin ;
Geynisman, Daniel M. .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (03) :463-466
[39]   Avelumab first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone in Asian patients with advanced urothelial carcinoma (UC): JAVELIN Bladder 100 subgroup analysis. [J].
Eto, Masatoshi ;
Lee, Jae-Lyun ;
Park, Se Hoon ;
Tsuchiya, Norihiko ;
Su, Po-Jung ;
Chan, T. W. ;
Desai, Chirag Jyotiker ;
Di Pietro, Alessandra ;
Wang, Jing ;
Laliberte, Robert J. ;
Gao, Seasea ;
Gurney, Howard .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[40]   Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial [J].
Powles, Thomas ;
Sridhar, Srikala S. ;
Loriot, Yohann ;
Bellmunt, Joaquim ;
Mu, Xinmeng Jasmine ;
Ching, Keith A. ;
Pu, Jie ;
Sternberg, Cora N. ;
Petrylak, Daniel P. ;
Tambaro, Rosa ;
Dourthe, Louis M. ;
Alvarez-Fernandez, Carlos ;
Aarts, Maureen ;
di Pietro, Alessandra ;
Grivas, Petros ;
Davis, Craig B. .
NATURE MEDICINE, 2021, 27 (12) :2200-+
12345